256 related articles for article (PubMed ID: 31077000)
1. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.
Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
Neurotox Res; 2019 Aug; 36(2):306-322. PubMed ID: 31077000
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.
Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
Mol Neurobiol; 2019 Oct; 56(10):7056-7073. PubMed ID: 30972627
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.
Maes M; Vojdani A; Geffard M; Moreira EG; Barbosa DS; Michelin AP; Semeão LO; Sirivichayakul S; Kanchanatawan B
Biomol Concepts; 2019 Nov; 10(1):209-225. PubMed ID: 31734647
[TBL] [Abstract][Full Text] [Related]
4. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
5. In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.
Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
Neurotox Res; 2019 Apr; 35(3):684-698. PubMed ID: 30552634
[TBL] [Abstract][Full Text] [Related]
6. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.
Maes M; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
Mol Neurobiol; 2021 Jul; 58(7):3319-3334. PubMed ID: 33675500
[TBL] [Abstract][Full Text] [Related]
8. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
Kanchanatawan B; Sriswasdi S; Maes M
Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
[TBL] [Abstract][Full Text] [Related]
9. Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning.
Kanchanatawan B; Sriswasdi S; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Kubera M; Maes M
Metab Brain Dis; 2018 Aug; 33(4):1053-1067. PubMed ID: 29527624
[TBL] [Abstract][Full Text] [Related]
10. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
[TBL] [Abstract][Full Text] [Related]
11. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
12. In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
Maes M; Andrés-Rodríguez L; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
CNS Neurol Disord Drug Targets; 2023; 22(2):215-225. PubMed ID: 35946099
[TBL] [Abstract][Full Text] [Related]
13. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
Kanchanatawan B; Maes M
CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
[TBL] [Abstract][Full Text] [Related]
15. Increased IgA-mediated responses to the gut paracellular pathway and blood-brain barrier proteins predict delirium due to hip fracture in older adults.
Thisayakorn P; Thipakorn Y; Tantavisut S; Sirivichayakul S; Vojdani A; Maes M
Front Neurol; 2024; 15():1294689. PubMed ID: 38379706
[TBL] [Abstract][Full Text] [Related]
16. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach.
Maes M; Sirivichayakul S; Matsumoto AK; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Carvalho AF; Solmi M; Kanchanatawan B
Mol Neurobiol; 2020 Nov; 57(11):4578-4597. PubMed ID: 32754898
[TBL] [Abstract][Full Text] [Related]
17. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B
Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions.
Beard RS; Reynolds JJ; Bearden SE
Blood; 2011 Aug; 118(7):2007-14. PubMed ID: 21705496
[TBL] [Abstract][Full Text] [Related]
19. IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety.
Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
CNS Neurol Disord Drug Targets; 2017; 16(4):472-483. PubMed ID: 28403801
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.
Fiorentino M; Sapone A; Senger S; Camhi SS; Kadzielski SM; Buie TM; Kelly DL; Cascella N; Fasano A
Mol Autism; 2016; 7():49. PubMed ID: 27957319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
